Indegene Ltd
NSE:INDGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Novocure Ltd
NASDAQ:NVCR
|
JE |
Indegene Ltd
Long-Term Debt
Indegene Ltd
Long-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
I
|
Indegene Ltd
NSE:INDGN
|
Long-Term Debt
724m
|
CAGR 3-Years
18%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
A
|
Abate As Industries Ltd
BSE:531658
|
Long-Term Debt
₹34.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Premier Capital Services Ltd
BSE:511016
|
Long-Term Debt
₹0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
One Point One Solutions Ltd
NSE:ONEPOINT
|
Long-Term Debt
₹293.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Rudrabhishek Enterprises Ltd
NSE:REPL
|
Long-Term Debt
₹3.3m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sagility India Ltd
NSE:SAGILITY
|
Long-Term Debt
₹10.2B
|
CAGR 3-Years
-40%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Indegene Ltd
Glance View
Indegene Ltd. is an intriguing tale of how technology and healthcare can converge to redefine industry standards. Established in 1998, this Bangalore-based company has strategically positioned itself at the intersection of life sciences, digital marketing, and healthcare solutions. Indegene capitalizes on providing tailored solutions to pharmaceutical and healthcare companies, leveraging its unique expertise in analytics, research, and digital innovation. With the constant need for improved healthcare delivery and a more personalized patient experience, Indegene addresses these demands by offering a comprehensive suite of services that includes medical, marketing, and managed care solutions. It helps its clients to navigate the complexities of regulatory landscapes, optimize pharmaceutical commercialization, and harness the power of data-driven medical research. The financial engine behind Indegene's success lies in its ability to seamlessly blend domain expertise with digital prowess. The company generates revenue primarily through long-term contracts with some of the world's leading life sciences companies. By providing strategic insights and operational execution in areas such as content management, omni-channel marketing, and commercialization strategy, Indegene empowers its clients to optimize their business processes, engage more effectively with healthcare professionals, and ultimately enhance patient outcomes. Its investment in building proprietary platforms and cutting-edge technology tools has enabled it to offer scalable, efficient solutions that are both cost-effective and inherently innovative, ensuring that Indegene remains a pivotal player in the ever-evolving healthcare landscape.
See Also
What is Indegene Ltd's Long-Term Debt?
Long-Term Debt
724m
Based on the financial report for Mar 31, 2025, Indegene Ltd's Long-Term Debt amounts to 724m .
What is Indegene Ltd's Long-Term Debt growth rate?
Long-Term Debt CAGR 3Y
18%
Over the last year, the Long-Term Debt growth was -82%. The average annual Long-Term Debt growth rates for Indegene Ltd have been 18% over the past three years .